Marker Therapeutics, Inc.

Marker Therapeutics, Inc.

Biotechnology • Healthcare • Houston, TX, United States • MRKR (NCM)

Marker Therapeutics, Inc., a clinical-stage immuno-oncology company, engages in the development and commercialization of novel T cell-based immunotherapies for the treatment of hematological malignancies and solid tumor indications. Its multi tumor associated antigen-specific T cell technology is based on the manufacture of non-engineered tumor-specific T cells that recognize multiple tumor-associated antigens. The company also develops MT-401-OTS for the treatment of acute myeloid leukemia AND myelodysplastic syndromes; and MT-601 to treat lymphoma and pancreatic cancer. Marker Therapeutics, Inc. is headquartered in Houston, Texas.

713 400 6400 2450 Holcombe Blvd, Houston, TX 77021, United States

Stock Performance (90 Days)

Data through Dec 26, 2025
Price updates on page refresh. Intraday quotes available during market hours (9:30 AM - 4:00 PM EST).

Layoff History

No layoff events recorded for this company.

Recent News

Here's Why We're Watching Marker Therapeutics' (NASDAQ:MRKR) Cash Burn Situation - Yahoo Finance
Yahoo Finance • Jul 11
H.C. Wainwright reiterates Buy rating on Marker Therapeutics stock - Investing.com
Investing.com • Dec 8
HC Wainwright & Co. Initiates Coverage of Marker Therapeutics (MRKR) with Buy Recommendation - Nasdaq
Nasdaq • Dec 8
Marker Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Updates - GlobeNewswire
GlobeNewswire • Nov 14
Marker Therapeutics Faces Major Shift amidst Strategic Challenges - StocksToTrade
StocksToTrade • Aug 26

Other Biotechnology Companies

View All →
CODEXIS, INC. logo Codexis, Inc.
1 layoff tracked
$144.5M market cap
VERTEX PHARMACEUTICALS INC / MA logo Vertex Pharmaceuticals Inc. / MA
$118.68B market cap
REGENERON PHARMACEUTICALS, INC. logo Regeneron Pharmaceuticals, Inc.
$82.72B market cap
ALNYLAM PHARMACEUTICALS, INC. logo Alnylam Pharmaceuticals, Inc.
$52.92B market cap
ARGENX SE logo Argenx SE
$52.62B market cap
INSMED Inc logo Insmed Inc.
$37.61B market cap

Frequently Asked Questions

Has Marker Therapeutics, Inc. had layoffs?
No layoff events have been recorded for Marker Therapeutics, Inc. in our database. This could mean the company has not conducted significant layoffs, or any layoffs have not been publicly reported.
How many employees does Marker Therapeutics, Inc. have?
Marker Therapeutics, Inc. has approximately 5 employees.
What industry is Marker Therapeutics, Inc. in?
Marker Therapeutics, Inc. operates in the Biotechnology industry, within the Healthcare sector.
Is Marker Therapeutics, Inc. a publicly traded company?
Yes, Marker Therapeutics, Inc. is publicly traded under the ticker symbol MRKR on the NCM. The company has a market capitalization of approximately $0.02 billion.
Where is Marker Therapeutics, Inc. headquartered?
Marker Therapeutics, Inc. is headquartered in Houston, TX, United States at 2450 Holcombe Blvd, Houston, TX 77021, United States.

Disclaimer

Data aggregated from public sources including WARN notices, SEC filings, press releases, and market data. While we strive for accuracy, information is provided "as-is" for informational purposes only. Always verify critical information with official company sources.

This information does not constitute investment, financial, legal, or career advice. See our Terms of Service, Privacy Policy, and About page for more information.

Found an error? Report it here.